Non-small Cell Lung Cancer Study US75 (Z-PACT)

Completed · Phase 3

Conditions studied: Non Small Cell Lung Carcinoma

In brief

This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.

Key facts

Study ID
NCT00086268
Run by
Novartis Pharmaceuticals
People needed
250
Starts
2004-04-01
Expected to finish
2007-10-01
Last updated by the study team
2017-09-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.